October University for Modern Sciences and Arts Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2016
NCT03716765
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

October University for Modern Sciences and Arts | october university of modern sciences and arts

Active Ingredients

Drugs in Phase 4 Trials (1)

platelet rich fibrin (2 trials)

Drugs in Phase 3 Trials (3)

hyaluronic acid (1 trial)

insulin human (humulin) (1 trial)

metformin (glucophage) (2 trials)

Drugs in Phase 1 Trials (1)

curcuma longa (1 trial)

Drugs in Other Trials (2)

onabotulinumtoxinA (Botox) (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 7